Murine thrombosis models

Sharlene M. Day; Jennifer L. Reeve; Daniel D. Myers; William P. Fay

doi:10.1055/s-0037-1613739

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2004; 92(03): 486-494
DOI: 10.1055/s-0037-1613739

Theme Issue Article

Schattauer GmbH

Murine thrombosis models

Authors

Sharlene M. Day

¹Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
Jennifer L. Reeve

¹Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA
Daniel D. Myers

²Surgery, University of Michigan Medical School, Ann Arbor, Michigan, USA
William P. Fay

¹Departments of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan, USA

Abstract

Summary

Due to exciting advances in molecular biology, the laboratory mouse has become an important and frequently used model for studying thrombosis. This article reviews several experimental approaches that have been used to study arterial, venous, and microvascular thrombosis in mice. The advantages and limitations of different models are examined. Related topics of mouse anesthesia, phlebotomy, and in vitro hemostasis testing are also reviewed.

Keywords

Mouse or murine - animal models - thrombosis - haemostasis

Volltext

Referenzen

References
1 Tsakiris DA, Scudder L, Hodivala-Dilke K. et al. Hemostasis in the mouse (mus musculus): a review. Thromb Haemost 1999; 81: 177-88.
2 Hogan KA, Weiler H, Lord ST. Mouse models in coagulation. Thromb Haemost 2002; 87: 563-74.
3 Kurz KD, Main BW, Sandusky GE. Rat model of arterial thrombosis induced by ferric chloride. Thromb Res 1990; 60: 269-80.
4 Farrehi PM, Ozaki CK, Carmeliet P. et al. Regulation of arterial thrombolysis by plasminogen activator inhibitor-1 in mice. Circulation 1998; 97: 1002-8.
5 Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99: 3050-5.
6 Denis C, Methia N, Frenette PS. et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci 1998; 95: 9524-9.
7 Matsuno H, Uematsu T, Nagashima S. et al. Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model. J Pharmacol Methods 1991; 25: 303-17.
8 Kikuchi S, Umemura K, Kondo K. et al. Photochemically induced endothelial injury in the mouse as a screening model for inhibitors of vascular intimal thickening. Arterioscler Thromb Vasc Biol 1998; 18: 1069-78.
9 Saniabadi AR, Umemura K, Matsumoto N. et al. Vessel wall injury and arterial thrombosis induced by a photochemical reaction. Thromb Haemost 1995; 73: 868-72.
10 Eitzman DT, Westrick RJ, Xu Z. et al. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2000; 20: 1831-4.
11 Eitzman DT, Westrick RJ, Nabel EG. et al. Plasminogen activator inhibitor-1 and vitronectin promote vascular thrombosis in mice. Blood 2000; 95: 577-80.
12 Myers DD, Hawley AE, Farris DM. et al. Pselectin and leukocyte microparticles are associated with venous thrombogensis. J Vasc Surg 2003; 38: 1075-89.
13 Angelillo-Scherrer A, Garcia Pde Frutos, Aparicio C. et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nature Med 2001; 07: 215-21.
14 Pierangeli SS, Liu XW, Barker JH. et al. Induction of thrombosis in a mouse by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome. Thromb Haemost 1995; 74: 1361-7.
15 Pierangeli SS, Barker JH, Stikovac D. et al. Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 1994; 71: 670-4.
16 Oury C, Kuijpers MJE, Toth-Zsamboki E. et al. Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype. Blood 2003; 101: 3969-76.
17 Andre P, Delaney SM, LaRocca T. et al. P2Y12 regulates platelet adhesion/activation, thrombus growth, and thrombus stability in injured arteries. J Clin Invest 2003; 112: 398406.
18 Rosen ED, Raymond S, Zollman A. et al. Laser-induced noninvasive vascular injury models in mice generate platelet- and coagulation- dependent thrombi. American Journal of Pathology 2001; 158: 1613-22.
19 Falati S, Gross P, Merrill-Skoloff G. et al. Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nature Med 2002; 08: 1175-80.
20 Carmeliet P, Stassen JM, Schoonjans L. et al. Plasminogen activator inhibitor-1 gene-deficient mice. II. Effects on hemostasis, thrombosis, and thrombolysis. J Clin Invest 1993; 92: 2756-60.
21 Bdeir K, Murciano J-C, Tomaszewski J. et al. Urokinase mediates fibrinolysis in the pulmonary microvasculature. Blood 2000; 96: 1820-6.
22 Broze Jr GJ, Yin Z-F, Lasky N. A tail vein bleeding time model and delayed bleeding in hemophiliac mice. Thromb Haemost 2001; 85: 747-8.
23 Ware J, Russell S, Ruggeri ZM. Generation and rescue of a murine model of platelet dysfunction: the Bernard-Soulier syndrome. Proc Natl Acad Sci 2000; 97: 2803-8.
24 Peng L, Mundada L, Stomel JM. et al. Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis. Antiox Redox Signal. In press.
25 Kahn M, Zheng Y-W, Huang W. et al. A dual thrombin receptor system for platelet activation. Nature 1998; 394: 690-4.
26 Cui J, Eitzman DT, Westrick RJ. et al. Spontaneous thrombosis in mice carrying the factor V leiden mutation. Blood 2000; 96: 4222-6.
27 Eitzman DT, Westrick RJ, Bi X. et al. Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden. Circulation 2002; 105: 2139-42.
28 Konstantinides S, Schafer K, Thinnes T. et al. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 2001; 103: 576-83.